Denmark
KLIFO is a North-European drug development consultancy founded in 1994 with a focus on accelerating progress in the Health Care and Pharmaceutical industries. The company's slogan "Accelerating progress, together" underlines their collaborative approach with pharmaceutical and biotech companies. KLIFO offers end-to-end solutions across all drug development areas, including strategic project management, regulatory affairs, clinical development, clinical trial supply, quality assurance (QA), Chemistry Manufacturing and Controls (CMC) development, non-clinical development, and pharmacovigilance.
With offices in Denmark, Sweden, Germany, and The Netherlands, KLIFO has established a significant presence in the North-European region and employs more than 150 highly skilled employees. Their extensive experience in partnering with pharmaceutical and biotech companies enables them to maximize opportunities, mitigate risks, drive innovation, and achieve efficient project advancement. KLIFO not only provides operational support but also offers strategic advice and collaborates with clients on portfolio strategies, project development strategies, and project execution.
While no specific details about the headquarters or last investment are available at the moment, KLIFO's track record and diverse range of services position them as a potential player in the pharmaceutical and biotech consulting landscape. Their emphasis on partnership and collaboration sets them apart as a promising entity in the drug development consultancy sector, with the potential to attract interest from venture capitalists seeking opportunities in the health and pharmaceutical industries.
